[PDF][PDF] SARS-CoV-2 突变株Omicron 家族的演化传播和流行现状
郑嘉豪， 王琼， 练仲豪， 黄勋 - 激光生物学报 - jgsw.hunnu.edu.cn
… Emergence BQ.1 and BQ.1.1 as newly identified omicron subvariants: current scenario and
future outlook ― an update [J]. Annals of Medicine and Surgery (2012), 2023, 85(4): 1329-…
future outlook ― an update [J]. Annals of Medicine and Surgery (2012), 2023, 85(4): 1329-…
[HTML][HTML] 2021 年新冠病毒变异, 跨种传播及疫苗和药物研究热点回眸
杨婧， 荣文婉， 桓瑜， 龚玉环， 毕玉海 - 科技导报, 2022 - kjdb.org
… Retrospect and prospect of SARS-CoV-2 in 2021: Genetic mutation… SARS-CoV-2 between
humans and animals in 2021. Next, we describe the development and effectiveness of current …
humans and animals in 2021. Next, we describe the development and effectiveness of current …
[HTML][HTML] 不同表达系统的治疗性纳米抗体研究进展
孙白荷， 吴悦， 赵芮， 楼雨馨， 李婉婷… - 中国生物工程 …, 2023 - manu60.magtech.com.cn
… The nanobodies existing in the sera of camels and sharks have different structural
characteristics and molecular weight from traditional monoclonal antibodies, as well as such …
characteristics and molecular weight from traditional monoclonal antibodies, as well as such …
[HTML][HTML] 臺灣茶對嚴重特殊傳染性肺炎COVID-19 之棘蛋白和血管收縮素轉化酶2 之間接合能力的影響
JH Hsieh - 2022 - ir.lib.ncu.edu.tw
… agents from Ayurveda against coronaviruses amidst the current formidable scenario: an in
silico … “In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2.” Journal of …
silico … “In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2.” Journal of …
“国际公共卫生紧急事件” 下的mRNA 疫苗研发
叶青， 秦成峰 - 合成生物学, 2024 - synbioj.cip.com.cn
… activity against SARS-like viruses by an engineered human monoclonal antibody[J]. Science…
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor …
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor …
[HTML][HTML] 噬菌体作为指示病毒的应用研究进展
孙廷丽， 韩玉茹， 王青柏， 黎玉莲， 谢小保 - 微生物学报, 2023 - actamicro.ijournals.cn
… prospects for the research and application of bacteriophages as indicator viruses in the future.
… 另有多项研究表明MS2具有比包膜病毒更强的环境抗性,可以作为SARS-CoV-2,肝炎等病毒的…
… 另有多项研究表明MS2具有比包膜病毒更强的环境抗性,可以作为SARS-CoV-2,肝炎等病毒的…
[PDF][PDF] 喷雾剂临床应用及质量控制研究进展
张鹰楠， 许子艺， 卢光照， 鲁莹， 张翮 - 药学实践杂志, 2024 - yxsj.smmu.edu.cn
… scenarios are increasingly extensive. In this review the clinical application status of sprays
and the latest … 苗能够有效防止上呼吸道和下呼吸道的SARS-CoV-2 感染,促进全身免疫反应;夏宁…
and the latest … 苗能够有效防止上呼吸道和下呼吸道的SARS-CoV-2 感染,促进全身免疫反应;夏宁…
建立表達單一第一型白血球抗原的人造抗原呈現細胞以刺激T 細胞及抗原表位定位
趙佳儀 - 2022 - tdr.lib.ntu.edu.tw
… Since monoclonal antibodies that are specific for the … Furthermore, we used pan-HLA-ABC
monoclonal antibodies, … -19, and the frequency of SARSCoV-2 specific memory T cells might …
monoclonal antibodies, … -19, and the frequency of SARSCoV-2 specific memory T cells might …